Advanced Search

 

Study ID Status Title Patient Level Data
SUM40157 Completed A double-blind, placebo-controlled, crossover-designed study, to evaluate the efficacy of oral sumatriptan (100mg) in the acute treatment of perimenstrual migraine attacks.
SUM40204 Completed Imitrex® Post-Marketing Surveillance Study.
SUM40218 Completed A double blind study to compare acute sumatriptan with Migril in the treatment of migraine.
SUM40220 Completed A single-blind study to rechallenge patients who had previously experienced an adverse event involving discomfort or pain in the chest or throat following sumatriptan administration (SC or oral). Rechallenge outside of a migraine attack with subcutaneous sumatriptan 6mg.
SUM40229 Completed A randomised, multicentre, double-blind, double-dummy, parallel-group study to compare the efficacy and safety of subcutaneous sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine.
SUM40241 Completed A study to investigate the effects of subcutaneous sumatriptan on cardiac haemodynamics in patients with existing or suspected coronary artery disease.
SUM40252 Completed An open, randomized, three-way crossover study in healthy subjects to evaluate the bioequivalence and taste acceptability of two different 20mg/100?L sumatriptan nasal spray formulations compared to the current 20mg/100?L sumatriptan nasal spray market formulation following single dose administr ...
SUM40254 Completed A study to investigate the single dose pharmacokinetics of sumatriptan nasal spray in pediatric subjects outside a migraine attack
SUM40255 Completed Open, pilot study to evaluate the efficacy, tolerability and safety of a combination of sumatriptan oral (50mg) + oral metoclopramide (10mg) + oral aspirin (900mg) in the treatment of a single migraine attack in patients not usually pain free during previous attacks, with the following molecules ...
SUM40257 Completed A randomised, multi-centre, open-label, crossover study to evaluate patient preference for sumatriptan 50mg and 100mg, naratriptan 2.5mg, rizatriptan 10mg and zolmitriptan 2.5mg tablets in the acute treatment of migraine.
SUM40260 Completed Patient Preference for and Satisfaction With Migraine Therapy: IMITREX® Tablets Versus Pre-Study Non-Triptan Therapy.Imitrex is a registered trademark of GlaxoSmithKline.
SUM40265 Completed A prospective multicentre study investigating the association between disability (as measured by the headache impact test, HIT-6) and IHS migraine classification (as determined by expert panel diary review) and to observe any changes in HIT-6 score following treatment with oral sumatriptan 50mg.
SUM40272 Completed An open-label, randomized, cross-over study to investigate the potential pharmacokinetic interaction of sumatriptan and clarithromycin when co-administered to healthy volunteers.
SUM40273 Completed An open-label study to investigate the potential pharmacokinetic interaction of sumatriptan and an oral contraceptive when co-administered to healthy volunteers.
SUM40274 Completed Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Attack Evaluation of Sumatriptan Tablets 50 mg and 100 mg Versus Placebo During a Migraine Headache at the First Sign of Pain.
SUM40275 Completed Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Attack Evaluation of Sumatriptan Tablets 50 mg and 100 mg Versus Placebo During a Migraine Headache at the First Sign of Pain.
SUM40276 Completed Final study report for protocol SUM40276 entitled “An open-label, long-term observational study ofthe safety and tolerability of sumatriptan nasal spray in the treatment of migraine in adolescents.”
SUM40282 Completed A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of Sumatriptan 50mg and 100mg Tablets Administered During the Mild Pain Phase of a Menstrually-Associated Migraine Attack Study Listed on ClinicalStudyDataRequest.com
SUM40285 Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Evaluation of Sumatriptan 50mg and 100mg Tablets Administered During the Mild Pain Phase of a Menstrually-Associated Migraine Attack Study Listed on ClinicalStudyDataRequest.com
SUM40286 Completed A randomized, double-blind, placebo-controlled, parallel-group, single-attack study of sumatriptan 6 mg injection in the treatment of moderate-to-severe migraine present upon awakening. Study Listed on ClinicalStudyDataRequest.com
SUM40287 Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Attack Study of Sumatriptan 6 mg Injection In the Treatment of Moderate-to-Severe Migraine Present Upon Awakening. Study Listed on ClinicalStudyDataRequest.com
SUM40291 Completed A randomized, double-blind, placebo-controlled, parallel-group, single-attack evaluation of sumatriptan 50mg and 100mg versus placebo during a migraine headache at the first sign of pain.
SUM40292 Completed A randomised, multi-centre, single-blind, cross-over study to investigate the efficacy and safety of sumatriptan 25mg suppositories compared to naproxen 500mg suppositories in the acute, early treatment of migraine in patients suffering from nausea and/or vomiting during their attacks.
SUM40294 Completed Identification of Migraine Headache Among Self-Described and/or Physician Diagnosed Sinus Headache Sufferers and Treatment with IMITREX† 50mg Tablets Study Listed on ClinicalStudyDataRequest.com
SUM40298 Completed A randomized, double-blind, placebo-controlled, single-attack, parallel-group evaluation of the efficacy of sumatriptan 50mg tablets versus placebo in the treatment of self-described and/or physician-diagnosed sinus headaches that meet International Headache Society (IHS) criteria for migraine headache. Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.